ACH

Accendra Health, Inc.
ACH

Upgrade to unlock
Buy
Hold
Sell

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
Avg. target
$4
86% upside
High target

1 analyst rating

positive
1  neutral
100%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
UBS
UBS
Kevin Caliendo
0% 1-yr ACH win rate
3 Nov ‘25 2 months ago